Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial)

Evaluation of ‘Dabigatran versus Warfarin in the treatment of acute venous thromboembolism'. N Engl J Med 2009;361:2342-52

Paolo Prandoni University of Padua, Department of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, Via Giustiniani 2, 35128 Padua, Italy +39 049 8212656; +39 049 8218731; [email protected]

, MD PhD &

Ali Taher American University of Beirut Medical Center, Department of Internal Medicine, Beirut, Lebanon

, MD

Abstract

In this clinical trial evaluation, we revisit the RE-COVER study, a large multicenter, randomized, double-blind, noninferiority trial on patients with acute venous thromboembolism treated with dabigatran versus warfarin. Study design and key results are re-evaluated in the context of previous work and future perspectives.

Keywords::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial)

Evaluation of ‘Dabigatran versus Warfarin in the treatment of acute venous thromboembolism'. N Engl J Med 2009;361:2342-52

Information for

Open access

Opportunities

Help and information

Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial)

Evaluation of ‘Dabigatran versus Warfarin in the treatment of acute venous thromboembolism'. N Engl J Med 2009;361:2342-52

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature